1. Home
  2. VKTX vs HIW Comparison

VKTX vs HIW Comparison

Compare VKTX & HIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VKTX
  • HIW
  • Stock Information
  • Founded
  • VKTX 2012
  • HIW 1978
  • Country
  • VKTX United States
  • HIW United States
  • Employees
  • VKTX N/A
  • HIW N/A
  • Industry
  • VKTX Biotechnology: Pharmaceutical Preparations
  • HIW Real Estate Investment Trusts
  • Sector
  • VKTX Health Care
  • HIW Real Estate
  • Exchange
  • VKTX Nasdaq
  • HIW Nasdaq
  • Market Cap
  • VKTX 2.8B
  • HIW 3.1B
  • IPO Year
  • VKTX 2015
  • HIW 1994
  • Fundamental
  • Price
  • VKTX $27.55
  • HIW $29.96
  • Analyst Decision
  • VKTX Buy
  • HIW Buy
  • Analyst Count
  • VKTX 12
  • HIW 6
  • Target Price
  • VKTX $84.00
  • HIW $32.50
  • AVG Volume (30 Days)
  • VKTX 4.3M
  • HIW 904.8K
  • Earning Date
  • VKTX 04-23-2025
  • HIW 04-29-2025
  • Dividend Yield
  • VKTX N/A
  • HIW 6.70%
  • EPS Growth
  • VKTX N/A
  • HIW 32.01
  • EPS
  • VKTX N/A
  • HIW 1.60
  • Revenue
  • VKTX N/A
  • HIW $819,789,000.00
  • Revenue This Year
  • VKTX N/A
  • HIW $0.41
  • Revenue Next Year
  • VKTX N/A
  • HIW $5.13
  • P/E Ratio
  • VKTX N/A
  • HIW $18.37
  • Revenue Growth
  • VKTX N/A
  • HIW N/A
  • 52 Week Low
  • VKTX $18.92
  • HIW $24.07
  • 52 Week High
  • VKTX $81.81
  • HIW $36.78
  • Technical
  • Relative Strength Index (RSI)
  • VKTX 53.68
  • HIW 64.28
  • Support Level
  • VKTX $26.37
  • HIW $28.86
  • Resistance Level
  • VKTX $30.28
  • HIW $29.72
  • Average True Range (ATR)
  • VKTX 1.65
  • HIW 0.78
  • MACD
  • VKTX 0.27
  • HIW 0.23
  • Stochastic Oscillator
  • VKTX 56.53
  • HIW 96.37

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

About HIW Highwoods Properties Inc.

Highwoods Properties Inc is a real estate investment trust engaged in the acquisition, ownership, management, and leasing of properties in urban areas throughout the Southern United States. In terms of total square footage, the vast majority of the company's real estate portfolio comprises office buildings in terms. Highwoods Properties derives nearly all of its income in the form of rental revenue from the tenants of its buildings. The majority of this revenue comes from its holdings in the urban markets of Atlanta, Raleigh, Nashville, and Tampa. These cities also account for the majority of the square footage under the company's ownership. Highwoods Properties' largest customers include the U.S. Government, financial services firms, industrial supply retailers, and healthcare companies.

Share on Social Networks: